Caris Life Sciences, Inc.

CAI · Healthcare

$24.78

Capitalización: 7B USDRendimiento por dividendo: —
Advance¿Es buen momento para comprar Caris Life Sciences, Inc.? Pregunta a Copenvest AIObtén una lectura Advance con IA sobre timing, riesgo y qué hacen los inversores rastreados.Preguntar a Copenvest AI

Cargando gráfico…

Noticias

Últimos titulares de esta acción

Simply Wall St.6 sept 2026, 10:11

Could Caris Life Sciences (CAI) Be 7% Undervalued After Its Lung Cancer Research Update?

Simply Wall St.5 sept 2026, 18:11

Caris Life Sciences (CAI) Will Present Seven Studies At A Global Lung Conference

Barrons.com5 sept 2026, 6:00

China Is Quietly Bracing for AI’s Social Costs

PR Newswire2 sept 2026, 12:30

Caris Life Sciences to Present New Research Advancing Precision Oncology at the IASLC 2026 World Conference on Lung Cancer

GlobeNewswire1 sept 2026, 14:00

New York Plastic Surgical Group Welcomes Two New Surgeons to Its Team